Rota, Hazel E.
HRN: 29-20-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/16/2026
07/22/2026
IV
500mg
Q8
Cholecystolithiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes